Mark Pollack to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Mark Pollack has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.078
-
Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16.
Score: 0.078